BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6247053)

  • 1. Carcinoma metastatic to the anterior ocular segment: response to chemotherapy.
    Sierocki JS; Charles NC; Schafrank M; Wittes RE
    Cancer; 1980 May; 45(10):2521-3. PubMed ID: 6247053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of vindesine in patients with small cell lung carcinoma.
    Natale RB; Gralla RJ; Wittes RE
    Cancer Treat Rep; 1981; 65(1-2):129-31. PubMed ID: 6261946
    [No Abstract]   [Full Text] [Related]  

  • 3. Iris metastasis in small-cell lung carcinoma.
    Roenhorst AW; van den Bergh AC; van Putten JW; Smit EF
    J Thorac Oncol; 2007 Dec; 2(12):1128-9. PubMed ID: 18090588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of vindesine plus mitomycin in stage-3 non-small cell lung cancer. An active regimen for outpatient treatment.
    Kris MG; Gralla RJ; Kelsen DP; Casper ES; Burke MT; Fiore JJ; Cibas IR; Heelan RT
    Chest; 1985 Mar; 87(3):368-72. PubMed ID: 2982552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of vindesine in patients with refractory small cell lung cancer.
    Chang AY; Witte RS; Tormey DC; Ramirez G
    Cancer Treat Rep; 1984 Nov; 68(11):1407-8. PubMed ID: 6094003
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase II trail of vindesine in patients with refractory small-cell carcinoma of the lung.
    Fuks JZ; Aisner J; Carney DN; Van Echo DA; Ostrow SS; Ihde DC; Wiernik PH
    Am J Clin Oncol; 1982 Feb; 5(1):49-52. PubMed ID: 6282108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the response of human lung carcinoma xenografts to vindesine and vincristine.
    Evans BD; Smith IE; Shorthouse AJ; Millar JL
    Br J Cancer; 1982 Mar; 45(3):466-8. PubMed ID: 6280742
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemotherapy of metastatic non-small cell bronchogenic carcinoma.
    Hoffman PC; Bitran JD; Golomb HM
    Semin Oncol; 1983 Mar; 10(1):111-22. PubMed ID: 6301062
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II evaluation of vindesine in non-small cell bronchogenic carcinoma.
    Hutcheon AW; Palmer JB; Pratt MA; Clark RA
    Cancer Treat Rep; 1983 Nov; 67(11):1041-2. PubMed ID: 6315231
    [No Abstract]   [Full Text] [Related]  

  • 10. Iris metastasis.
    Ramos Suárez A; Guerrero Mayor OV; Fernández Barrientos Y; Lorenzo Soto M
    Med Clin (Barc); 2017 Jan; 148(2):e11. PubMed ID: 27255986
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitomycin, hexamethylmelamine, and vindesine as second-line treatment for small cell cancer of the lung.
    Joss RA; Brunner KW; Goldhirsch A
    Cancer Treat Rep; 1982 Oct; 66(10):1873-4. PubMed ID: 6290051
    [No Abstract]   [Full Text] [Related]  

  • 13. Carcinoma metastatic to the eye and orbit II. A clinicopathological study of 26 patients with carcinoma metastatic to the anterior segment of the eye.
    Ferry AP; Font RL
    Arch Ophthalmol; 1975 Jul; 93(7):472-82. PubMed ID: 166633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent small cell lung carcinoma with vindesine and cisplatin.
    Niederle N; Schütte J; Schmidt CG; Seeber S
    Cancer Treat Rep; 1984 May; 68(5):791-2. PubMed ID: 6327037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II study of vindesine in patients with carcinoma of the lung and metastatic pulmonary tumor].
    Shibuya M; Saijo N; Shimizu E; Eguchi K; Shinkai T; Tominaga K; Shimabukuro Z
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1808-13. PubMed ID: 6307176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of vindesine, cisplatin, and hexamethylmelamine (VCH) in small cell carcinoma of the lung.
    Daugaard G; Hansen HH; Rørth M
    Cancer Treat Rep; 1984 Sep; 68(9):1179-81. PubMed ID: 6090016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vindesine in bronchogenic carcinoma: a phase II trial.
    Vogelzang NJ; Peterson BA; Kennedy BJ; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1982 Feb; 5(1):41-4. PubMed ID: 6282107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vindesine in the treatment of small cell anaplastic bronchogenic carcinoma.
    Osterlind K; Dombernowsky P; Sørensen PG; Hansen HH
    Cancer Treat Rep; 1981; 65(3-4):245-8. PubMed ID: 6263469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complete regression of eyeball metastasis secondary to non-small-cell lung cancer with Cisplatin and Vinorelbin therapy].
    Kostrzewska M; Nowak-Gabryel M; Gabryel M
    Pol Merkur Lekarski; 2011 Sep; 31(183):171-4. PubMed ID: 21991848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of non-small cell bronchial cancer with high-dosage cisplatin and vindesine. Results of a prospective study].
    König HJ; Arnold E; Walter M; Sander U
    Fortschr Med; 1984 Sep; 102(33):811-4. PubMed ID: 6090286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.